by vesalius | Oct 26, 2021 | Events
Calla TMVr System, our comprehensive transfemoral DMR solution, will be unveiled to the clinical community in a podium presentation in the Innovation Theatre on November 4, 3PM local time. Please come and check us out! The Transcatheter Cardiovascular Therapeutics...
by vesalius | Oct 26, 2021 | Events
For the fifth consecutive year, Vesalius has been selected to pitch during Invest In BC, a major and very select yearly event organized by Life Sciences British Columbia and presented by Lumira Ventures. Over two days, November 3rd and 4th, the event will bring...
by vesalius | Apr 28, 2021 | Events
The Vesalius Team joins the 2021 Vancouver Sun Run Virtual Race. This year, due to the pandemic, participants were asked to choose the circuit and the time/date to run, between April 18th and 30th. The Team chose the Stanley Park route, the epitome of Vancouver...
by vesalius | Apr 21, 2021 | Press Releases
VANCOUVER, BC, April 21, 2021 /PRNewswire/ — Vesalius Cardiovascular Inc. (VCI), a Canadian MedTech company developing a Transfemoral Mitral Valve Repair (TMVr) solution, announced today the achievement of a new pre-clinical milestone with its...
by vesalius | Apr 14, 2021 | Awards & Recognition
March 23, 2021 – Ready to Rocket, British Columbia (BC) This annual event showcases the top technology companies that are best positioned to capitalize on the largest growth trends in the technology industry. For the fourth consecutive year, Vesalius is...
Recent Comments